Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings

Fortress Biotech (NASDAQ: FBIO) has announced it completed the second and final stage of the previously-announced sale of its remaining holdings of National Holdings.

As quoted in the press release:

Pursuant to the terms of the stock purchase agreement dated November 14, 2018 (the “Purchase Agreement”).  B. Riley, along with two other minority purchaser designees, collectively purchased the remaining NHLD shares held by Fortress for an aggregate price of approximately $13.1 million ($22.9 million across the entire transaction).

Click here to read the full press release.